Correction

Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial (vol 28, pg 128, 2017)

Journal

ANNALS OF ONCOLOGY
Volume 29, Issue 10, Pages 2152-2152

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/annonc/mdx805

Keywords

-

Categories

Funding

  1. NIH/NCI Cancer Center Support Grant [P30 CA008748]

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Recommended

No Data Available
No Data Available